Condition: Urothelial Carcinoma · Urothelial Carcinoma Recurrent · Urothelial Carcinoma Ureter · Sponsor: UroGen Pharma Ltd.
The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.
This description comes directly from the study's public registry record.
Michael Louie, MD, MPH, MSc · 855-987-6436 · registry@urogen.com
Always discuss trial participation with your own doctor first.
| Providence St. Johns Health Center | Santa Monica, California, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Mount Sinai Medical Center of Florida, Inc. | Miami, Florida, United States | Recruiting |
| H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. | Tampa, Florida, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| The State University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Chesapeake Urology | Baltimore, Maryland, United States | Recruiting |
| Johns Hopkins Medical Center | Baltimore, Maryland, United States | Recruiting |
| Mass General Hospital (MGH) | Boston, Massachusetts, United States | Recruiting |
| The Brigham and Womens Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05874921